BMS at ECTRIMS 2021

Intended for U.S. scientific audiences only.

The 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is an important opportunity to reinforce our commitment to help, with the goal of preserving physical and cognitive functions in people living with multiple sclerosis (MS) through scientific exchange on research and breakthroughs. We look forward to showcasing new research and sharing progress with the MS community.

Our Data at ECTRIMS 2021

Read more about our key data being presented at the meeting.

At ECTRIMS 2021, Bristol Myers Squibb is presenting multiple abstracts with new research findings in appropriate patients with relapsing forms of MS.

Our Science & Commitment

We are pursuing pathbreaking science and innovative solutions to potentially improve outcomes in MS. Read how our team is working to delay progression and prevent disability for individuals diagnosed with MS.

Delivering Meaningful Innovations for the Multiple Sclerosis Community >

Learn about how Bristol Myers Squibb is focused on delivering meaningful innovations to help, with the goal of preserving physical and cognitive functions in people living with MS.

How BMS Supports the MS Community: A Q&A with Cathy Trzaskawka and Richard Nieman >

Hear from Cathy Trzaskawka (Traz), executive director, Bristol Myers Squibb Patient Advocacy, and Richard Nieman, senior vice president, Worldwide Medical, Immunology & Fibrosis, to learn how Bristol Myers Squibb's work in MS goes beyond the medicine, and how the company supports the entire community.

Resources

Learn more about our research in MS through the resources below.

Multiple Sclerosis >

Learn about the different types of multiple sclerosis and its potential impact on patients.

Multiple Sclerosis and the Brain >

Learn more about multiple sclerosis and how it affects the brain. 

Music Therapy and Multiple Sclerosis >

Learn more about the relationship between multiple sclerosis and music therapy.